Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment.
Saved in:
| Title: | Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment. |
|---|---|
| Authors: | de Weerdt I; Department of Hematology, Cancer Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Hofland T; Department of Hematology, Cancer Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., de Boer R; Department of Hematology, Cancer Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Dobber JA; Department of Hematology, Cancer Center Amsterdam, and., Dubois J; Department of Hematology, Cancer Center Amsterdam, and., van Nieuwenhuize D; Department of Hematology, Cancer Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Mobasher M; Genentech Inc., South San Francisco, CA., de Boer F; Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands., Hoogendoorn M; Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Velders GA; Department of Internal Medicine, Gelderse Vallei Hospital, Ede, The Netherlands., van der Klift M; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Remmerswaal EBM; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bemelman FJ; Renal Transplant Unit, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Niemann CU; Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Kersting S; Department of Hematology, Haga Hospital, The Hague, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands; and., Eldering E; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands., Tonino SH; Department of Hematology, Cancer Center Amsterdam, and.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands., Kater AP; Department of Hematology, Cancer Center Amsterdam, and.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands. |
| Source: | Blood advances [Blood Adv] 2019 Sep 10; Vol. 3 (17), pp. 2642-2652. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
